A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO - PubMed (original) (raw)
Comparative Study
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
D G R Evans et al. J Med Genet. 2004 Jun.
Abstract
Purpose: To develop a simple scoring system for the likelihood of identifying a BRCA1 or BRCA2 mutation.
Methods: DNA samples from affected subjects from 422 non-Jewish families with a history of breast and/or ovarian cancer were screened for BRCA1 mutations and a subset of 318 was screened for BRCA2 by whole gene screening techniques. Using a combination of results from screening and the family history of mutation negative and positive kindreds, a simple scoring system (Manchester scoring system) was devised to predict pathogenic mutations and particularly to discriminate at the 10% likelihood level. A second separate dataset of 192 samples was subsequently used to test the model's predictive value. This was further validated on a third set of 258 samples and compared against existing models.
Results: The scoring system includes a cut-off at 10 points for each gene. This equates to >10% probability of a pathogenic mutation in BRCA1 and BRCA2 individually. The Manchester scoring system had the best trade-off between sensitivity and specificity at 10% prediction for the presence of mutations as shown by its highest C-statistic and was far superior to BRCAPRO.
Conclusion: The scoring system is useful in identifying mutations particularly in BRCA2. The algorithm may need modifying to include pathological data when calculating whether to screen for BRCA1 mutations. It is considerably less time-consuming for clinicians than using computer models and if implemented routinely in clinical practice will aid in selecting families most suitable for DNA sampling for diagnostic testing.
Comment in
- Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
Evans DG, Lalloo F, Wallace A, Rahman N. Evans DG, et al. J Med Genet. 2005 Jul;42(7):e39. doi: 10.1136/jmg.2005.031989. J Med Genet. 2005. PMID: 15994864 Free PMC article. No abstract available.
Similar articles
- Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN. Oros KK, et al. Clin Genet. 2006 Oct;70(4):320-9. doi: 10.1111/j.1399-0004.2006.00673.x. Clin Genet. 2006. PMID: 16965326 - Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.
Simard J, Dumont M, Moisan AM, Gaborieau V, Malouin H, Durocher F, Chiquette J, Plante M, Avard D, Bessette P, Brousseau C, Dorval M, Godard B, Houde L; INHERIT BRCAs; Joly Y, Lajoie MA, Leblanc G, Lépine J, Lespérance B, Vézina H, Parboosingh J, Pichette R, Provencher L, Rhéaume J, Sinnett D, Samson C, Simard JC, Tranchant M, Voyer P, Easton D, Tavtigian SV, Knoppers BM, Laframboise R, Bridge P, Goldgar D. Simard J, et al. J Med Genet. 2007 Feb;44(2):107-21. doi: 10.1136/jmg.2006.044388. Epub 2006 Aug 11. J Med Genet. 2007. PMID: 16905680 Free PMC article. - Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
Antonucci I, Provenzano M, Sorino L, Balsamo M, Aceto GM, Battista P, Euhus D, Cianchetti E, Ballerini P, Natoli C, Palka G, Stuppia L. Antonucci I, et al. J Hum Genet. 2017 Mar;62(3):379-387. doi: 10.1038/jhg.2016.138. Epub 2016 Dec 8. J Hum Genet. 2017. PMID: 27928164 - Development of a scoring system to screen for BRCA1/2 mutations.
Evans GR, Lalloo F. Evans GR, et al. Methods Mol Biol. 2010;653:237-47. doi: 10.1007/978-1-60761-759-4_14. Methods Mol Biol. 2010. PMID: 20721747 Review. - Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.
Mazzola E, Blackford A, Parmigiani G, Biswas S. Mazzola E, et al. Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Cancer Inform. 2015. PMID: 25983549 Free PMC article. Review.
Cited by
- Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
Joseph G, Kaplan C, Luce J, Lee R, Stewart S, Guerra C, Pasick R. Joseph G, et al. Public Health Genomics. 2012;15(3-4):172-80. doi: 10.1159/000336419. Epub 2012 Apr 4. Public Health Genomics. 2012. PMID: 22488460 Free PMC article. Clinical Trial. - Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.
James PA, Sawyer S, Boyle S, Young MA, Kovalenko S, Doherty R, McKinley J, Alsop K, Beshay V, Harris M, Fox S, Lindeman GJ, Mitchell G. James PA, et al. Fam Cancer. 2015 Jun;14(2):287-95. doi: 10.1007/s10689-015-9785-0. Fam Cancer. 2015. PMID: 25678442 - Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA. Palmero EI, et al. Genet Mol Biol. 2016 May 13;39(2):168-77. doi: 10.1590/1678-4685-GMB-2014-0364. Genet Mol Biol. 2016. PMID: 27192127 Free PMC article. - Breast cancer risk-assessment models.
Evans DG, Howell A. Evans DG, et al. Breast Cancer Res. 2007;9(5):213. doi: 10.1186/bcr1750. Breast Cancer Res. 2007. PMID: 17888188 Free PMC article. Review. - Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.
Lindor NM, Lindor RA, Apicella C, Dowty JG, Ashley A, Hunt K, Mincey BA, Wilson M, Smith MC, Hopper JL. Lindor NM, et al. Fam Cancer. 2007;6(4):473-82. doi: 10.1007/s10689-007-9150-z. Epub 2007 Jul 17. Fam Cancer. 2007. PMID: 17636425 Free PMC article.
References
- J Med Genet. 2000 Oct;37(10):792-4 - PubMed
- Clin Genet. 2000 Oct;58(4):299-308 - PubMed
- Hum Pathol. 2000 Nov;31(11):1420-4 - PubMed
- Br J Cancer. 2001 Mar 2;84(5):704-8 - PubMed
- J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous